160 related articles for article (PubMed ID: 23928249)
1. Magnetic resonance spectroscopy of the breast: current status.
Bolan PJ
Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):625-39. PubMed ID: 23928249
[TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
3. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
Booth SJ; Pickles MD; Turnbull LW
BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
[TBL] [Abstract][Full Text] [Related]
4. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
[TBL] [Abstract][Full Text] [Related]
5. L-COSY of breast cancer at 3T.
Ramadan S; Baltzer PA; Lin A; Stanwell P; Box H; Kaiser WA; Mountford CE
Eur J Radiol; 2012 Sep; 81 Suppl 1():S129-31. PubMed ID: 23083559
[No Abstract] [Full Text] [Related]
6. Quantitative multivoxel proton chemical shift imaging of the breast.
Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
[TBL] [Abstract][Full Text] [Related]
7. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
9. Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.
Sah RG; Sharma U; Parshad R; Seenu V; Mathur SR; Jagannathan NR
Magn Reson Med; 2012 Oct; 68(4):1039-47. PubMed ID: 22213087
[TBL] [Abstract][Full Text] [Related]
10. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
11. Breast magnetic resonance imaging for monitoring response to therapy.
Ojeda-Fournier H; de Guzman J; Hylton N
Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):533-46. PubMed ID: 23928243
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
13. MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.
Bolan PJ; Kim E; Herman BA; Newstead GM; Rosen MA; Schnall MD; Pisano ED; Weatherall PT; Morris EA; Lehman CD; Garwood M; Nelson MT; Yee D; Polin SM; Esserman LJ; Gatsonis CA; Metzger GJ; Newitt DC; Partridge SC; Hylton NM;
J Magn Reson Imaging; 2017 Jul; 46(1):290-302. PubMed ID: 27981651
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation: the role of MRS.
Jiang L; Wijnen JP; Glunde K
Eur J Radiol; 2012 Sep; 81 Suppl 1():S66-8. PubMed ID: 23083608
[No Abstract] [Full Text] [Related]
15. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
Bolan PJ; Meisamy S; Baker EH; Lin J; Emory T; Nelson M; Everson LI; Yee D; Garwood M
Magn Reson Med; 2003 Dec; 50(6):1134-43. PubMed ID: 14648561
[TBL] [Abstract][Full Text] [Related]
16. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
Başara I; Örgüç Ş; Coşkun T
Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
[TBL] [Abstract][Full Text] [Related]
17. Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy.
Leong KM; Lau P; Ramadan S
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):268-77. PubMed ID: 25913106
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
[TBL] [Abstract][Full Text] [Related]
19. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
20. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer.
Seenu V; Pavan Kumar MN; Sharma U; Gupta SD; Mehta SN; Jagannathan NR
Magn Reson Imaging; 2005 Dec; 23(10):1005-10. PubMed ID: 16376185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]